(Q37874615)

24 August 2017

1 reference

title

Tovaxin for multiple sclerosis (English)

1 reference

24 August 2017

0 references

Victor M Rivera

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

12 May 2011

1 reference

Expert Opinion on Biological Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

961-967

1 reference

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Innate immunity in inflammatory bowel disease: a disease hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Multiple sclerosis immunology: The healthy immune system vs the MS immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

The role of the CD58 locus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

T cell vaccination in secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

T cell vaccination in multiple sclerosis: results of a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.584866

10.1517/14712598.2011.584866

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference